China, Aug. 14 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'Study on the Regulatory Mechanism of Uveitis Recurrence Mediated by Macrophage P2X7 Receptor via Gut Dysbiosis and Blood–Retinal Barrier Breakdown'. The following are the other relevant details related to the trial:
Registration Number: ChiCTR2600130054
Registration Time: 2026/08/13
Type: Observational study
Primary Sponsor: Peking University People's Hospital
To know more, click on https://www.chictr.org.cn/showprojEN.html?proj=336315
Published by HT Digital Content Services with permission from Health Daily Digest....